Not logged in Real-world healthcare resource utilization and clinical outcomes among patients with relapsed/refractory multiple myeloma receiving ciltacabtagene autoleucel after four or more prior lines of therapy in inpatient versus outpatient settings Janakiram, Murali; Fan, Lin; Ghosh, Sabyasachi; Alegria, Victoria; Perciavalle, Matthew; Emond, Bruno; Maitland, Jessica; Bixby, Todd; Nagar, Saurabh P.; Qureshi, Zaina P.; Dima, Danai Share Save
Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease Cummings, Jeffrey L.; Agadjanyan, Michael G.; Barry, Maureen; Corey, Lawrence; Doody, Rachelle; Hendrix, Suzanne; Mattke, Soeren; Mattsson-Carlgren, Niklas; Mcdade, Eric; Menetski, Joseph P.; Mohs, Richard C.; Partrick, Katherine A.; Petrovsky, Nikolai; Selkoe, Dennis J.; Silva, Diego; Sperling, Reisa A.; Tiede, Benjamin; Vradenburg, George Share Save
TECLISTAMY (EMN40): A PHASE 2 TRIAL OF TECLISTAMAB IN PATIENTS WITH PREVIOUSLY TREATED LIGHT-CHAIN AL AMYLOIDOSIS Roussel, M.; Kastritis, E.; Schonland, S. O.; Kortum, K. M.; Arnulf, B.; Jaccard, A.; Vara, S.; Doyle, M.; Schecter, J. M.; Carpinteiro, A.; Kwok, F.; Palladini, G.; Minnema, M. C.; Boccadoro, M.; Sonneveld, P. Share Save
EFFECTIVENESS OF BRIDGING THERAPY CORRESPONDS TO IMPROVED OUTCOMES AFTER CILTACABTAGENE AUTOLEUCEL: PHASE 3 CARTITUDE-4 STUDY OF PATIENTS WITH RELAPSED, LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA Zamagni, E.; Dhakal, B.; Iida, S.; Sidiqi, M. H.; Yoon, S. S.; Callander, N.; Touzeau, C.; Li, Q.; Balogh, A.; Slaughter, A.; Benachour, N.; Lonardi, C.; Ghosh, A.; Vogel, M.; Lendvai, N.; Lengil, T.; Koneru, M.; Patel, N.; Costa Filho, O.; Mahajan, V.; Martinez-Lopez, J.; Yong, K.; Weisel, K.; Leleu, X. Share Save
CILTACABTAGENE AUTOLEUCEL OUT-OF-SPECIFICATION MANUFACTURING OUTCOMES IMPROVE WITH EARLIER LINES OF THERAPY Bowden, R.; Van Eeckhoutte, H.; Chow, G.; Choudhary, G.; Kallenbach, L.; Alegria, V.; Perciavalle, M.; Salmon, J.; Kang, J.; Mondon, M.; Vanak, J.; Ciccone, D.; Millili, P.; Onorata, M.; Plaks, V.; Merz, M. Share Save
SAFETY AND EFFICACY OF TALQUETAMAB plus TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM PHASE 1B OF REDIRECTT-1: RESULTS WITH AN EXTENDED MEDIAN FOLLOW-UP OF 3 YEARS Ocio, E. M.; Mateos, M-V.; Magen, H.; Gatt, M.; Sebag, M.; Kim, K.; Min, C-K.; Yoon, S-S.; Chu, M. P.; Rodriguez-Otero, P.; Avivi, I.; Carde, N. A. Quijano; Krevvata, M.; Henninger, T.; Thakkar, P.; Festa, M.; Huang, L.; Zhou, J. X.; Takamoto, M.; Pei, L.; Lu, J.; Maffucci, C.; Scott, E.; Oriol, A.; Morillo, D.; Cohen, Y. C. Share Save
EARLIER USE OF CILTACABTAGENE AUTOLEUCEL IS ASSOCIATED WITH BETTER IMMUNE FITNESS AND STRONGER IMMUNE EFFECTS AS SHOWN BY CORRELATIVE ANALYSIS OF PERIPHERAL BLOOD AND THE BONE MARROW TUMOR MICROENVIRONMENT FROM THE CARTITUDE-4 STUDY van de Donk, N. W. C. J.; Parekh, S.; Li, K.; Lin, Y.; Martin, T. G.; Han, S.; De Oca, R. Montes; Suraneni, M.; Gormley, M.; Hodkinson, B.; Yuan, J.; Wang, F.; Kumar, A.; Yin, D.; Smirnov, D.; Patel, J.; Lendvai, N.; Madduri, D.; Zhu, J.; Koneru, M.; Patel, N.; Geng, D.; Plaks, V.; Harrison, S. Share Save
Share Save
LONG-TERM PROGRESSION-FREE SURVIVAL BENEFIT WITH CILTACABTAGENE AUTOLEUCEL IN STANDARD-RISK RELAPSED/REFRACTORY MULTIPLE MYELOMA Dytfeld, D.; Costa, L. J.; Oriol, A.; Manier, S.; Voorhees, P. M.; Lin, Y.; Htut, M.; Roeloffzen, W.; Ho, P. J.; Shah, U.; Zhao, M.; Li, Q.; Balogh, A.; Li, K.; Slaughter, A.; Benachour, N.; Lonardi, C.; Ghosh, A.; Sun, H.; Lendvai, N.; Lengil, T.; Patel, N.; Koneru, M.; Florendo, E.; Filho, O. Costa; Mahajan, V.; Rodriguez-Otero, P.; Strous, C.; Stewart, A. K.; Sidana, S. Share Save
A randomized, double-blind, placebo-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of inflammatory bowel disease: safety and colonization dynamics of a novel live biotherapeutic product in healthy adults Silber, Jeffrey L.; Norman, Jason M.; Kanno, Tokuwa; Crossette, Emily M.; Szabady, Rose; Menon, Rajita; Marko, Melissa; Hao, Ling-Yang; Tomsho, Lynn; Bhagat, Sunita; Yuan, Anna; Olle, Bernat; Lamouse-Smith, Esi Share Save
Share Save
Impact of non-tumor size related features on staging in non-small cell lung cancer: a population-level analysis of the SEER-medicare database Rajaram, Ravi; Johnson, Barbara H.; Huang, Qing; Laxmanan, Balaji; Johnston, Stephen; Hasan, Aisha; Giuffre, James M.; Kalsekar, Iftekhar; Vachani, Anil; Robinson, Clifford; Devisetty, Kiran Share Save
Share Save
Multivalent display of membrane proteins using HIV-1 Gag VLPs Bhat, Neha A.; Dunn, Nicholas; Yu, Xiaodi; Duprie, Matthew; Dutta, Supratik; McLean, Matthew; Feldkamp, Micheal D.; Kratch, Jacqueline; Mann, Mandeep K.; Rahighi, Simin; Davidson, Robert C.; Leppard, John B.; Cheung, Wan Cheung; Khandelwal, Puneet Share Save
Share Save
Share Save
Share Save
Med.ai ASK: an agentic system for biomedical question answering Nguyen, Nhung T. H.; Lituiev, Dmytro S.; Liu, Zhimin; Kashyap, Aditya; Jenkinson, Garrett; Kuhl, Kevin; Corrado, Christopher; Patel, Naisargi Manishkumar; Snigdha, Kirti; Saeedi, Sirwe; Smith, David; Baro, Nicholas; Schultz, Timothy Share Save
Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
